Ligand Pharmaceuticals (NASDAQ: LGND)
Ligand Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ligand Pharmaceuticals Company Info
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
News & Analysis
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir.
3 Signs the Ligand Short Squeeze Is Over
The Reddit crowd wasn't the only reason short-sellers got burned betting against this pharmaceutical company.
Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now
The unusual biotech could be a bitter pill for short sellers to swallow.
Short-Sellers Have These 3 ETFs in Their Sights
Should investors watch for a squeeze?
Ligand Trounces Q2 Estimates by Helping Companies Make COVID-19 Drug Remdesivir
The company posted strong revenue and earnings growth in Q2 and upped its full-year outlook.
Here's Why Ligand Pharmaceuticals Is Having a Bad Day
Investors are not impressed with the company's plan to finance an acquisition spree.
Here's Why Ligand Pharmaceuticals Plummeted 16% Today
When Citron speaks, investors listen -- but should they?
3 Top Healthcare Stocks to Buy Right now
Find out why a medical device maker, a gene sequencer, and a drug licensing company have our team of healthcare experts feeling bullish.
Valuation
Earnings Transcripts
Ligand Pharmaceuticals Incorporated (LGND) Q3 2021 Earnings Call Transcript
LGND earnings call for the period ending September 30, 2021.
Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript
LGND earnings call for the period ending June 30, 2021.
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
LGND earnings call for the period ending March 31, 2021.
Ligand Pharmaceuticals Inc (LGND) Q4 2020 Earnings Call Transcript
LGND earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.